Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pircher

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Memo|January 18, 2021
ASCO 2020 non-small lung cancer (NSCLC) personal highlightsLena Horvath, Andreas Pircher
Frontiers in Oncology|July 2, 2019
Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and TherapyIsabel Heidegger, Andreas Pircher, Renate Pichler
Translational Lung Cancer Research|March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug developmentWolfgang Hilbe, Christian Manegold, Andreas Pircher
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
Current Opinion in Urology|August 21, 2023
Pembrolizumab in mCRPC - Combination therapies as breakthrough to success?Stefan Plas, Andreas Pircher, Isabel Heidegger
RNA Biology|February 19, 2015
Ribosome-associated ncRNAs: an emerging class of translation regulatorsAndreas Pircher, Jennifer Gebetsberger, Norbert Polacek
World Journal of Hepatology|March 23, 2011
Liver cancer: Targeted future optionsAndreas Pircher, Michael Medinger, Joachim Drevs
Onkologie|May 18, 2011
Cancer stem cells: characteristics and their potential role for new therapeutic strategiesStephan R Bohl, Andreas Pircher, Wolfgang Hilbe
Atherosclerosis|September 6, 2016
Endothelial cell metabolism: A novel player in atherosclerosis? Basic principles and therapeutic opportunitiesAndreas Pircher, Lucas Treps, Natalia Bodrug, et al.
Cancer Biology & Therapy|February 12, 2011
Targeting the insulin-like growth factor network in cancer therapyIsabel Heidegger, Andreas Pircher, Helmut Klocker, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Memo|January 18, 2021
ASCO 2020 non-small lung cancer (NSCLC) personal highlightsLena Horvath, Andreas Pircher
Frontiers in Oncology|July 2, 2019
Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and TherapyIsabel Heidegger, Andreas Pircher, Renate Pichler
Translational Lung Cancer Research|March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug developmentWolfgang Hilbe, Christian Manegold, Andreas Pircher
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
Current Opinion in Urology|August 21, 2023
Pembrolizumab in mCRPC - Combination therapies as breakthrough to success?Stefan Plas, Andreas Pircher, Isabel Heidegger
RNA Biology|February 19, 2015
Ribosome-associated ncRNAs: an emerging class of translation regulatorsAndreas Pircher, Jennifer Gebetsberger, Norbert Polacek
World Journal of Hepatology|March 23, 2011
Liver cancer: Targeted future optionsAndreas Pircher, Michael Medinger, Joachim Drevs
Onkologie|May 18, 2011
Cancer stem cells: characteristics and their potential role for new therapeutic strategiesStephan R Bohl, Andreas Pircher, Wolfgang Hilbe
Atherosclerosis|September 6, 2016
Endothelial cell metabolism: A novel player in atherosclerosis? Basic principles and therapeutic opportunitiesAndreas Pircher, Lucas Treps, Natalia Bodrug, et al.
Cancer Biology & Therapy|February 12, 2011
Targeting the insulin-like growth factor network in cancer therapyIsabel Heidegger, Andreas Pircher, Helmut Klocker, et al.
Pageof 10